Previous 10 | Next 10 |
PerkinElmer, Inc. (NYSE: PKI) , a global leader committed to innovating for a healthier world, today announced that it anticipates reported and organic revenue growth of approximately 35% and 33%, respectively, for the third quarter ended October 4, 2020. The strong revenue ...
Etsy (ETSY), PerkinElmer (PKI), Pool (POOL), and Deckers Outdoor (DECK) have gained significantly so far in 2020 based on their ability to capitalize on the pandemic. The long-term revenue and earnings growth potential of these companies should help their stocks perform even better in 2021. ...
Rushed to market just 6 months into the COVID-19 pandemic, the Pacer BioThreat Strategy ETF (VIRS) takes a unique approach to picking potential pandemic winners. The LifeSci BioThreat Strategy Index underlying VIRS selects holdings based on seven different criteria - everything from p...
COVID-19 has driven a sharp upturn in demand for PerkinElmer's ImmunoDiagnostic and Applied Genomics products, including RT-PCR kits, automated systems, and reagents. COVID-19 is likely to have a noticeable impact on birth rates, hurting the newborn screening business in 2021-2023. ...
Rushed to market just 6 months into the COVID-19 pandemic, the Pacer BioThreat Strategy ETF (VIRS) takes a unique approach to picking potential pandemic winners. The LifeSci BioThreat Strategy Index underlying VIRS selects holdings based on seven different criteria - everything from p...
Shortages of reagents, essential chemicals used in diagnostic assays, are the latest supply issue hampering U.S. health systems in their efforts to offer COVID-19 tests to all who need or request them. Some hospitals and other testing operations have returned to restricting tests to the most ...
Needham has upgraded PerkinElmer ( PKI +4.0% ) to Buy from Hold with a $139 price target (17% upside), also adding the stock to his Conviction Buy list. More news on: PerkinElmer, Inc., Healthcare stocks news, Read more ...
PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the BofA Global Healthcare Conference 2020 on Wednesday, September 16, 2020 at 10:05 a.m. ET. Prahlad Singh, president and chief executive offic...
Most growth investors focus on technology stocks but they should also consider the healthcare sector, where valuations are more reasonable. Veeva Systems Inc. (VEEV), ABIOMED, Inc. (ABMD), PerkinElmer, Inc. (PKI), and Charles River Laboratories International, Inc. (CRL) are four healthcare stoc...
PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at Baird's 2020 Virtual Global Healthcare Conference on Thursday, September 10, 2020 at 8:30 a.m. ET. Jamey Mock, senior vice president and chief f...
News, Short Squeeze, Breakout and More Instantly...
Revenue of $675 million; (30)% reported growth; (27)% organic growth; 6% non-COVID organic growth GAAP EPS of $4.50; Adjusted EPS from continuing operations of $1.01 Updates full year 2023 guidance Authorizes new $600 million share repurchase program To begin tradi...
Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges Trusted partner to pharma, government and diagnostics customers with complete, end-to-end solutions To begin trading as RVTY under new name on ...
2023-05-07 19:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...